Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 73

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 73
---
 transfer agent, VStock Transfer, LLC as of, 2025, 11:59 pm CET (record date), are entitled to participate personally or be represented as provided for herein in order to exercise their shareholder rights with respect to the NLS Meeting. During the period from, 2025 until and including, 2025, no entries of shares will be made in the shareholder register. Shareholders who sell part or all of their shares before the NLS Meeting are no longer entitled to vote to that extent. Holders of Common Shares or Preferred Shares, who are entered in the shareholder register at the record date, are entitled to vote at the NLS Meeting, whereby each Common Share and/or Preferred Share entitles its holder to one vote. Quorum and Vote of NLS’s Shareholders Neither Swiss law nor the Articles provide any quorum requirements applicable to the NLS Meeting. Therefore, any amount of NLS shareholders present or NLS Common Shares or NLS Preferred Shares represented at the NLS Meeting constitutes a quorum. The right to vote, and the other rights of share ownership, may only be exercised by shareholders (including any nominees) or usufructuaries (a person who has the right to enjoy the use and advantages of another’s property short of the destruction or waste of its substance), who are entered in our share register as of, 2025, 11:59 pm CET (record date). Pursuant to Swiss law, the NLS Meeting generally approves resolutions by an absolute majority of the shares represented at the shareholders’ meeting, or a Simple Majority Vote. In certain instances, however, Swiss law or the Articles require the NLS Meeting to approve a resolution by at least two -thirdsof the voting rights represented at the shareholders’ meeting and an absolute majority of the nominal value of shares represented at such meeting, or a Supermajority Vote. The NLS Meeting requires a Supermajority Vote for the following Proposals: •Proposal No. 2 to approve the ordinary share capital increase with contribution of the Kadimastem shares to implement the Merger. •Proposal No. 3 to approve the ordinary share capital increase regarding the issuance of preferred shares. •Proposal No. 4 to approve the reinstatement of the capital band. •Proposal No. 5 to approve the conditional share capital for employee and advisory options. •Proposal No. 6 to approve the conditional share capital for shareholders’ options. Proxy Solicitation Shareholders entitled to vote in the NLS Meeting may